Charles River Laboratories International Stock News

WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CRL--Charles River Laboratories Schedules Third-Quarter 2022 Earnings Release and Conference Call

Charles River's (CRL) latest product offering is expected to streamline the pathway to GMP AAV vector manufacturing without significant process development.

Charles River (CRL) continues to expect that the growth rate will approach 20% in the second half of 2022.

Charles River's (CRL) manufacturing collaboration with Cure AP-4 will support the latter's Phase I/II gene therapy trials for a rare neurodegenerative disorder.

Charles River Labs, or "CRL", provides critical discovery, clinical and safety services to nearly all biotech and pharma companies and has built a hard-earned reputation for quality. With rapid advanc

WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CRL--Charles River Laboratories to Present at September Conferences

Charles River (CRL) reported earnings 30 days ago. What's next for the stock?

In Q2, the impact of foreign currency translation reduces Charles River's (CRL) reported revenue growth by 3.4%.

Keeping a list of S&P 500 growth stocks you'd like to own is a good idea. And it might pay off sooner than you think.

Charles River Laboratories International, Inc. (NYSE:CRL ) Q2 2022 Earnings Conference Call August 3, 2022 9:30 AM ET Company Participants Todd Spencer – Vice President-Investor Relations Jim Foster

Revenue decline in the CDMO business drag Charles River's (CRL) Manufacturing Solutions revenues down.

Charles River (CRL) delivered earnings and revenue surprises of 1.09% and 2.54%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

The broad-based demand and meaningful price increases in the RMS business, particularly in North America and China, are expected to have contributed to Charles River's (CRL) Q2 top line.

WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CRL--Charles River Laboratories Schedules Second-Quarter 2022 Earnings Release and Conference Call

Investors are optimistic about Charles River's (CRL) strong segmental growth and notable collaborations.